Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Evolent Health, Maintains $44 Price Target By Benzinga Newsdesk February 23, 9:09 AM RBC Capital analyst Sean Dodge reiterates Evolent Health (NYSE:EVH) with a Outperform and maintains $44 price target. EVH
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Whitecap Res, Maintains C$14 Price Target By Benzinga Newsdesk February 23, 8:50 AM RBC Capital analyst Luke Davis reiterates Whitecap Res (TSX:WCP) with a Outperform and maintains C$14 price target. TSX:WCP
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Gildan Activewear, Maintains $39 Price Target By Benzinga Newsdesk February 23, 8:46 AM RBC Capital analyst Sabahat Khan reiterates Gildan Activewear (NYSE:GIL) with a Outperform and maintains $39 price target. GIL
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Denali Therapeutics, Maintains $105 Price Target By Benzinga Newsdesk February 23, 7:18 AM HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $105 price target. DNLI
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $87 Price Target By Benzinga Newsdesk February 23, 7:09 AM HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $87 price target. APLS
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on PowerSchool Holdings, Maintains $26 Price Target By Benzinga Newsdesk February 23, 6:50 AM Needham analyst Ryan MacDonald reiterates PowerSchool Holdings (NYSE:PWSC) with a Buy and maintains $26 price target. PWSC
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Dun & Bradstreet Hldgs, Maintains $18 Price Target By Benzinga Newsdesk February 23, 6:38 AM Needham analyst Kyle Peterson reiterates Dun & Bradstreet Hldgs (NYSE:DNB) with a Buy and maintains $18 price target. DNB
Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Market Perform on Kohl’s, Maintains $35 Price Target By Benzinga Newsdesk February 23, 6:36 AM Telsey Advisory Group analyst Dana Telsey reiterates Kohl's (NYSE:KSS) with a Market Perform and maintains $35 price target. KSS
Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Outperform on Zevia, Maintains $5.5 Price Target By Benzinga Newsdesk February 23, 6:04 AM Telsey Advisory Group analyst Dana Telsey reiterates Zevia (NYSE:ZVIA) with a Outperform and maintains $5.5 price target. ZVIA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Cowen & Co. Reiterates Outperform on Dutch Bros, Maintains $43 Price Target By Benzinga Newsdesk February 23, 5:22 AM Cowen & Co. analyst Andrew Charles reiterates Dutch Bros (NYSE:BROS) with a Outperform and maintains $43 price target. BROS